Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)
CompletedOBSERVATIONAL
Enrollment
109
Participants
Timeline
Start Date
January 1, 2021
Primary Completion Date
June 30, 2023
Study Completion Date
January 30, 2024
Conditions
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Trial Locations (1)
14000
CHU de Caen, Caen
All Listed Sponsors
lead
University Hospital, Caen
OTHER
NCT06416683 - Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen) | Biotech Hunter | Biotech Hunter